John P Brancaccio has bought stock on 2 days since Mar 2021

John P. Brancaccio is a non‑executive director of OKYO Pharma Ltd (NASDAQ: OKYO), where he serves on the board of the clinical‑stage biopharmaceutical company and has reported multiple equity and option holdings in the firm.( A retired CPA, he is a veteran financial executive with extensive domestic and international experience in the pharmaceutical, biotechnology, and medical device sectors for both privately and publicly held companies.( Recent regulatory filings show him as a corporate insider and director, including Form 3 and Form 4 filings disclosing his share ownership, option grants, and open‑market purchases of OKYO Pharma securities.(

Brancaccio’s earlier career includes service as Chief Financial Officer/Chief Operating Officer of Eline Group, an entertainment and media company, from 2000 to 2002; Chief Financial Officer of Memory Pharmaceuticals Corp., a biotechnology company, from May 2002 to March 2004; and Chief Financial Officer of Accelerated Technologies, Inc., a medical device incubator, from April 2004 to May 2017.( He currently holds board positions at several life sciences companies, including Cardiff Oncology, Inc., Hepion Pharmaceuticals, Inc., Rasna Therapeutics, Inc., Tiziana Life Sciences plc, and OKYO Pharma Ltd, where he often contributes audit and financial oversight expertise.( Public disclosures and insider‑trading reports consistently identify him as an individual director rather than a corporate entity.(

Written by Perplexity from public sources.